Generator, Chelator, and Kit Optimization (GeCKO): Bringing 44TI and 43/44gSc into Radiopharmacy Practice

Engle, Jonathan W., Boros, Eszter · 2026

Read Generator, Chelator, and Kit Optimization (GeCKO): Bringing 44TI and 43/44gSc into Radiopharmacy Practice by Engle, Jonathan W., Boros, Eszter (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/doe-osti-3377439-generator-chelator-and-kit-optimization.txt.

Description

Final technical report for grant DE-SC0023638, from the University of Wisconsin-Madison, covers the GeCKO project led by Jonathan W. Engle with Eszter Boros. The award ran from January 2023 to December 2025. GeCKO stands for Generator, Chelator, and Kit Optimization. Its aim is to bring titanium-44 and scandium-43 and -44 into radiopharmacy use. These isotopes suit PET scans, but supply chains and chemistry lag behind demand.

Work split into tasks on each side. One side probed titanium's chemistry to build solid-phase separation media from deferiprone ligands. The other side used scandium coordination chemistry to widen its use. A high point is a first full run of a solid-phase capture and light-release scheme. It produced a targeted scandium-44 drug aimed at PSMA, with a PET image to prove it. Trainees in both labs gained hands-on time with accelerator-made isotopes and mass spectrometry.

Catalog record

CREATOREngle, Jonathan W., Boros, Eszter
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE8 KB
LICENSEPublic Domain
RIGHTSPUBLIC DOMAIN
SOURCEDOE OSTI

Source: https://www.osti.gov/biblio/3377439

Browse the full library · About the Tower of Babel